Drugs market was valued at US$ 154940 million in 2023 and is anticipated to reach US$ 214040 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.

Over The Counter (OTC) Drugs Market

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.

The global Over The Counter (OTC)

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Over The Counter (OTC) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Over The Counter (OTC) Drugs.

Report Scope

The Over The Counter (OTC) Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Over The Counter (OTC) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Over The Counter (OTC) Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Over The Counter (OTC) Drugs Market Report

Report Metric	Details
Report Name	Over The Counter (OTC) Drugs Market
Accounted market size in 2023	US$ 154940 million
Forecasted market size in 2030	US$ 214040 million
CAGR	4.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Analgesics Dermatology Products Gastrointestinal Products Vitamins, Mineral, and Supplements (VMS) Weight Loss/Dietary Products Ophthalmic Products Sleeping Aids Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacy Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer AG, Merck KGaA, Novartis, Johnson & Johnson, GlaxoSmithKline, Alkem Laboratories, Teva Pharmaceutical Industries, Pfizer, Sun Pharma, Allergan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Over The Counter (OTC) Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Over The Counter (OTC) Drugs Market growing?

Ans: The Over The Counter (OTC) Drugs Market witnessing a CAGR of 4.6% during the forecast period 2024-2030.

What is the Over The Counter (OTC) Drugs Market size in 2030?

Ans: The Over The Counter (OTC) Drugs Market size in 2030 will be US$ 214040 million.

Who are the main players in the Over The Counter (OTC) Drugs Market report?

Ans: The main players in the Over The Counter (OTC) Drugs Market are Bayer AG, Merck KGaA, Novartis, Johnson & Johnson, GlaxoSmithKline, Alkem Laboratories, Teva Pharmaceutical Industries, Pfizer, Sun Pharma, Allergan

What are the Application segmentation covered in the Over The Counter (OTC) Drugs Market report?

Ans: The Applications covered in the Over The Counter (OTC) Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Others

What are the Type segmentation covered in the Over The Counter (OTC) Drugs Market report?

Ans: The Types covered in the Over The Counter (OTC) Drugs Market report are Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral, and Supplements (VMS), Weight Loss/Dietary Products, Ophthalmic Products, Sleeping Aids, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Analgesics

1.2.3 Dermatology Products

1.2.4 Gastrointestinal Products

1.2.5 Vitamins, Mineral, and Supplements (VMS)

1.2.6 Weight Loss/Dietary Products

1.2.7 Ophthalmic Products

1.2.8 Sleeping Aids

1.2.9 Others

1.3 Market by Application

1.3.1 Global Over The Counter (OTC) Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacy

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Over The Counter (OTC) Drugs Market Perspective (2019-2030)

2.2 Over The Counter (OTC) Drugs Growth Trends by Region

2.2.1 Global Over The Counter (OTC) Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Over The Counter (OTC) Drugs Historic Market Size by Region (2019-2024)

2.2.3 Over The Counter (OTC) Drugs Forecasted Market Size by Region (2025-2030)

2.3 Over The Counter (OTC) Drugs Market Dynamics

2.3.1 Over The Counter (OTC) Drugs Industry Trends

2.3.2 Over The Counter (OTC) Drugs Market Drivers

2.3.3 Over The Counter (OTC) Drugs Market Challenges

2.3.4 Over The Counter (OTC) Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Over The Counter (OTC) Drugs Players by Revenue

3.1.1 Global Top Over The Counter (OTC) Drugs Players by Revenue (2019-2024)

3.1.2 Global Over The Counter (OTC) Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Over The Counter (OTC) Drugs Revenue

3.4 Global Over The Counter (OTC) Drugs Market Concentration Ratio

3.4.1 Global Over The Counter (OTC) Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Over The Counter (OTC) Drugs Revenue in 2023

3.5 Over The Counter (OTC) Drugs Key Players Head office and Area Served

3.6 Key Players Over The Counter (OTC) Drugs Product Solution and Service

3.7 Date of Enter into Over The Counter (OTC) Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Over The Counter (OTC) Drugs Breakdown Data by Type

4.1 Global Over The Counter (OTC) Drugs Historic Market Size by Type (2019-2024)

4.2 Global Over The Counter (OTC) Drugs Forecasted Market Size by Type (2025-2030)

5 Over The Counter (OTC) Drugs Breakdown Data by Application

5.1 Global Over The Counter (OTC) Drugs Historic Market Size by Application (2019-2024)

5.2 Global Over The Counter (OTC) Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Over The Counter (OTC) Drugs Market Size (2019-2030)

6.2 North America Over The Counter (OTC) Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Over The Counter (OTC) Drugs Market Size by Country (2019-2024)

6.4 North America Over The Counter (OTC) Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Over The Counter (OTC) Drugs Market Size (2019-2030)

7.2 Europe Over The Counter (OTC) Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Over The Counter (OTC) Drugs Market Size by Country (2019-2024)

7.4 Europe Over The Counter (OTC) Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Over The Counter (OTC) Drugs Market Size (2019-2030)

8.2 Asia-Pacific Over The Counter (OTC) Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Over The Counter (OTC) Drugs Market Size (2019-2030)

9.2 Latin America Over The Counter (OTC) Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Over The Counter (OTC) Drugs Market Size by Country (2019-2024)

9.4 Latin America Over The Counter (OTC) Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Over The Counter (OTC) Drugs Market Size (2019-2030)

10.2 Middle East & Africa Over The Counter (OTC) Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer AG

11.1.1 Bayer AG Company Detail

11.1.2 Bayer AG Business Overview

11.1.3 Bayer AG Over The Counter (OTC) Drugs Introduction

11.1.4 Bayer AG Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.1.5 Bayer AG Recent Development

11.2 Merck KGaA

11.2.1 Merck KGaA Company Detail

11.2.2 Merck KGaA Business Overview

11.2.3 Merck KGaA Over The Counter (OTC) Drugs Introduction

11.2.4 Merck KGaA Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.2.5 Merck KGaA Recent Development

11.3 Novartis

11.3.1 Novartis Company Detail

11.3.2 Novartis Business Overview

11.3.3 Novartis Over The Counter (OTC) Drugs Introduction

11.3.4 Novartis Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.3.5 Novartis Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Detail

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Over The Counter (OTC) Drugs Introduction

11.4.4 Johnson & Johnson Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.4.5 Johnson & Johnson Recent Development

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Detail

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Over The Counter (OTC) Drugs Introduction

11.5.4 GlaxoSmithKline Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.5.5 GlaxoSmithKline Recent Development

11.6 Alkem Laboratories

11.6.1 Alkem Laboratories Company Detail

11.6.2 Alkem Laboratories Business Overview

11.6.3 Alkem Laboratories Over The Counter (OTC) Drugs Introduction

11.6.4 Alkem Laboratories Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.6.5 Alkem Laboratories Recent Development

11.7 Teva Pharmaceutical Industries

11.7.1 Teva Pharmaceutical Industries Company Detail

11.7.2 Teva Pharmaceutical Industries Business Overview

11.7.3 Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Introduction

11.7.4 Teva Pharmaceutical Industries Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.7.5 Teva Pharmaceutical Industries Recent Development

11.8 Pfizer

11.8.1 Pfizer Company Detail

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Over The Counter (OTC) Drugs Introduction

11.8.4 Pfizer Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.8.5 Pfizer Recent Development

11.9 Sun Pharma

11.9.1 Sun Pharma Company Detail

11.9.2 Sun Pharma Business Overview

11.9.3 Sun Pharma Over The Counter (OTC) Drugs Introduction

11.9.4 Sun Pharma Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.9.5 Sun Pharma Recent Development

11.10 Allergan

11.10.1 Allergan Company Detail

11.10.2 Allergan Business Overview

11.10.3 Allergan Over The Counter (OTC) Drugs Introduction

11.10.4 Allergan Revenue in Over The Counter (OTC) Drugs Business (2019-2024)

11.10.5 Allergan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Teva Pharmaceutical Industries

Sun Pharma

Allergan plc

List of Tables

Table 1. Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Analgesics

Table 3. Key Players of Dermatology Products

Table 4. Key Players of Gastrointestinal Products

Table 5. Key Players of Vitamins, Mineral, and Supplements (VMS)

Table 6. Key Players of Weight Loss/Dietary Products

Table 7. Key Players of Ophthalmic Products

Table 8. Key Players of Sleeping Aids

Table 9. Key Players of Others

Table 10. Global Over The Counter (OTC) Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Over The Counter (OTC) Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 12. Global Over The Counter (OTC) Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 13. Global Over The Counter (OTC) Drugs Market Share by Region (2019-2024)

Table 14. Global Over The Counter (OTC) Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 15. Global Over The Counter (OTC) Drugs Market Share by Region (2025-2030)

Table 16. Over The Counter (OTC) Drugs Market Trends

Table 17. Over The Counter (OTC) Drugs Market Drivers

Table 18. Over The Counter (OTC) Drugs Market Challenges

Table 19. Over The Counter (OTC) Drugs Market Restraints

Table 20. Global Over The Counter (OTC) Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 21. Global Over The Counter (OTC) Drugs Market Share by Players (2019-2024)

Table 22. Global Top Over The Counter (OTC) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over The Counter (OTC) Drugs as of 2023)

Table 23. Ranking of Global Top Over The Counter (OTC) Drugs Companies by Revenue (US$ Million) in 2023

Table 24. Global 5 Largest Players Market Share by Over The Counter (OTC) Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 25. Key Players Headquarters and Area Served

Table 26. Key Players Over The Counter (OTC) Drugs Product Solution and Service

Table 27. Date of Enter into Over The Counter (OTC) Drugs Market

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Over The Counter (OTC) Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 30. Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2019-2024)

Table 31. Global Over The Counter (OTC) Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 32. Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2025-2030)

Table 33. Global Over The Counter (OTC) Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 34. Global Over The Counter (OTC) Drugs Revenue Market Share by Application (2019-2024)

Table 35. Global Over The Counter (OTC) Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 36. Global Over The Counter (OTC) Drugs Revenue Market Share by Application (2025-2030)

Table 37. North America Over The Counter (OTC) Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Over The Counter (OTC) Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Over The Counter (OTC) Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Over The Counter (OTC) Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Europe Over The Counter (OTC) Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 42. Europe Over The Counter (OTC) Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 43. Asia-Pacific Over The Counter (OTC) Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 44. Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 45. Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 46. Latin America Over The Counter (OTC) Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Latin America Over The Counter (OTC) Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 48. Latin America Over The Counter (OTC) Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 49. Middle East & Africa Over The Counter (OTC) Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 50. Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 51. Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 52. Bayer AG Company Detail

Table 53. Bayer AG Business Overview

Table 54. Bayer AG Over The Counter (OTC) Drugs Product

Table 55. Bayer AG Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 56. Bayer AG Recent Development

Table 57. Merck KGaA Company Detail

Table 58. Merck KGaA Business Overview

Table 59. Merck KGaA Over The Counter (OTC) Drugs Product

Table 60. Merck KGaA Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 61. Merck KGaA Recent Development

Table 62. Novartis Company Detail

Table 63. Novartis Business Overview

Table 64. Novartis Over The Counter (OTC) Drugs Product

Table 65. Novartis Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 66. Novartis Recent Development

Table 67. Johnson & Johnson Company Detail

Table 68. Johnson & Johnson Business Overview

Table 69. Johnson & Johnson Over The Counter (OTC) Drugs Product

Table 70. Johnson & Johnson Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 71. Johnson & Johnson Recent Development

Table 72. GlaxoSmithKline Company Detail

Table 73. GlaxoSmithKline Business Overview

Table 74. GlaxoSmithKline Over The Counter (OTC) Drugs Product

Table 75. GlaxoSmithKline Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 76. GlaxoSmithKline Recent Development

Table 77. Alkem Laboratories Company Detail

Table 78. Alkem Laboratories Business Overview

Table 79. Alkem Laboratories Over The Counter (OTC) Drugs Product

Table 80. Alkem Laboratories Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 81. Alkem Laboratories Recent Development

Table 82. Teva Pharmaceutical Industries Company Detail

Table 83. Teva Pharmaceutical Industries Business Overview

Table 84. Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Product

Table 85. Teva Pharmaceutical Industries Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 86. Teva Pharmaceutical Industries Recent Development

Table 87. Pfizer Company Detail

Table 88. Pfizer Business Overview

Table 89. Pfizer Over The Counter (OTC) Drugs Product

Table 90. Pfizer Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 91. Pfizer Recent Development

Table 92. Sun Pharma Company Detail

Table 93. Sun Pharma Business Overview

Table 94. Sun Pharma Over The Counter (OTC) Drugs Product

Table 95. Sun Pharma Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 96. Sun Pharma Recent Development

Table 97. Allergan Company Detail

Table 98. Allergan Business Overview

Table 99. Allergan Over The Counter (OTC) Drugs Product

Table 100. Allergan Revenue in Over The Counter (OTC) Drugs Business (2019-2024) & (US$ Million)

Table 101. Allergan Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Over The Counter (OTC) Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Over The Counter (OTC) Drugs Market Share by Type: 2023 VS 2030

Figure 3. Analgesics Features

Figure 4. Dermatology Products Features

Figure 5. Gastrointestinal Products Features

Figure 6. Vitamins, Mineral, and Supplements (VMS) Features

Figure 7. Weight Loss/Dietary Products Features

Figure 8. Ophthalmic Products Features

Figure 9. Sleeping Aids Features

Figure 10. Others Features

Figure 11. Global Over The Counter (OTC) Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 12. Global Over The Counter (OTC) Drugs Market Share by Application: 2023 VS 2030

Figure 13. Hospital Pharmacies Case Studies

Figure 14. Retail Pharmacies Case Studies

Figure 15. Online Pharmacy Case Studies

Figure 16. Others Case Studies

Figure 17. Over The Counter (OTC) Drugs Report Years Considered

Figure 18. Global Over The Counter (OTC) Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 19. Global Over The Counter (OTC) Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 20. Global Over The Counter (OTC) Drugs Market Share by Region: 2023 VS 2030

Figure 21. Global Over The Counter (OTC) Drugs Market Share by Players in 2023

Figure 22. Global Top Over The Counter (OTC) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over The Counter (OTC) Drugs as of 2023)

Figure 23. The Top 10 and 5 Players Market Share by Over The Counter (OTC) Drugs Revenue in 2023

Figure 24. North America Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. North America Over The Counter (OTC) Drugs Market Share by Country (2019-2030)

Figure 26. United States Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Canada Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Europe Over The Counter (OTC) Drugs Market Share by Country (2019-2030)

Figure 30. Germany Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia-Pacific Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Asia-Pacific Over The Counter (OTC) Drugs Market Share by Region (2019-2030)

Figure 38. China Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Japan Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. South Korea Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. India Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Australia Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Latin America Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Latin America Over The Counter (OTC) Drugs Market Share by Country (2019-2030)

Figure 46. Mexico Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Brazil Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Over The Counter (OTC) Drugs Market Share by Country (2019-2030)

Figure 50. Turkey Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Over The Counter (OTC) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Bayer AG Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 53. Merck KGaA Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 54. Novartis Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 55. Johnson & Johnson Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 56. GlaxoSmithKline Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 57. Alkem Laboratories Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 58. Teva Pharmaceutical Industries Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 59. Pfizer Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 60. Sun Pharma Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 61. Allergan Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2019-2024)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions